[{"NetIncomeLoss_3_Q3_USD":-186655000.0,"MarketableSecuritiesCurrent_0_Q3_USD":463531000.0,"GeneralAndAdministrativeExpense_3_Q3_USD":48988000.0,"GeneralAndAdministrativeExpense_1_Q3_USD":18711000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":69720000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":73706000.0,"CommitmentsAndContingencies_0_Q3_USD":null,"AccruedLiabilitiesCurrent_0_Q3_USD":24633000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":-174000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q3_USD":601927000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-391663000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_3_Q3_shares":2435102.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q3_USD":195000.0,"AssetsCurrent_0_Q3_USD":814774000.0,"MarketableSecuritiesRealizedGainLoss_3_Q3_USD":0.0,"ContractWithCustomerLiability_0_Q3_USD":119782000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q3_shares":6660000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":20365000.0,"CommonStockSharesIssued_0_Q3_shares":74342178.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q3_USD":813982000.0,"Assets_0_Q3_USD":1334961000.0,"ShareBasedCompensation_3_Q3_USD":32448000.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":81788000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_3_Q3_USD":29.8,"ProceedsFromIssuanceOfCommonStock_26_Q3_USD":1815700000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_3_Q3_USD":50.73,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1_Q3_USD":105.17,"EquityMethodInvestments_0_Q3_USD":62837000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":5073000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_3_Q3_USD":63.13,"RevenueFromRelatedParties_3_Q3_USD":277000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":158646000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":60486000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q3_USD":39.23,"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_3_Q3_shares":354072.0,"IncreaseDecreaseInAccruedLiabilities_3_Q3_USD":-1170000.0,"ProceedsFromStockPlans_3_Q3_USD":970000.0,"AccountsReceivableNetCurrent_0_Q3_USD":2491000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_3_Q3_pure":0.727,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_1_Q3_pure":0.752,"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_0_Q3_USD":54.26,"CommonStockValue_0_Q3_USD":7000.0,"DepreciationDepletionAndAmortization_3_Q3_USD":5011000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":734408000.0,"CostsAndExpenses_3_Q3_USD":207634000.0,"CostsAndExpenses_1_Q3_USD":79197000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_3_Q3_USD":390984000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-186830000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-71805000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":-1870000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_3_Q3_pure":0.009,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_1_Q3_pure":0.01,"OtherAssetsNoncurrent_0_Q3_USD":5165000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":334736000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":67273000.0,"AdditionalPaidInCapitalCommonStock_0_Q3_USD":1729029000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_0_Q3_shares":443285.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_3_Q3_USD":17.8,"RevenueFromRelatedParties_1_Q3_USD":277000.0,"CommonStockSharesAuthorized_0_Q3_shares":120000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":20199000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":7204000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":172366000.0,"IncreaseDecreaseInAccountsReceivable_3_Q3_USD":361000.0,"CommonStockSharesOutstanding_0_Q3_shares":74342178.0,"PaymentsToAcquireMarketableSecurities_3_Q3_USD":772759000.0,"ContractWithCustomerLiabilityRevenueRecognized_3_Q3_USD":16861000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q3_USD":-161000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q3_USD":22000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":15410000.0,"MarketableSecuritiesUnrealizedGainLoss_3_Q3_USD":-175000.0,"MarketableSecuritiesUnrealizedGainLoss_1_Q3_USD":-161000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-170379000.0,"MarketableSecuritiesNoncurrent_0_Q3_USD":350451000.0,"LiabilitiesCurrent_0_Q3_USD":97567000.0,"AccountsPayableCurrent_0_Q3_USD":7470000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":14016000.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":39868000.0,"ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress_3_Q3_USD":62900000.0,"OtherAccruedLiabilitiesCurrent_0_Q3_USD":2371000.0,"IncreaseDecreaseInOtherOperatingAssets_3_Q3_USD":248000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q3_USD":336972000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_3_Q3_shares":50946.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_3_Q3_shares":2636437.0,"CapitalExpendituresIncurredButNotYetPaid_3_Q3_USD":633000.0,"ProceedsFromIssuanceOfConvertiblePreferredStock_26_Q3_USD":85000000.0,"RestrictedCashEquivalents_0_Q3_USD":2236000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":19946000.0,"NetIncomeLoss_1_Q3_USD":-71644000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-621764000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q3_shares":1977984.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q3_shares":6216864.0,"AccountsReceivableRelatedPartiesCurrent_0_Q3_USD":200000.0,"OperatingIncomeLoss_3_Q3_USD":-187435000.0,"OperatingIncomeLoss_1_Q3_USD":-71993000.0,"ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized_3_Q3_USD":-17049000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_3_Q3_USD":255800000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_1_Q3_USD":171300000.0,"InvestmentIncomeInterest_3_Q3_USD":780000.0,"InvestmentIncomeInterest_1_Q3_USD":349000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_3_Q3_pure":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1_Q3_pure":0.0,"ContractWithCustomerLiabilityCurrent_0_Q3_USD":56759000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_3_Q3_USD":79.17,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_3_Q3_USD":15.12,"LiabilitiesAndStockholdersEquity_0_Q3_USD":1334961000.0,"IncreaseDecreaseInContractWithCustomerLiability_3_Q3_USD":-16986000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q3_USD":11828000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":15410000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0_Q3_USD":120800000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_3_Q3_shares":559241.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":8705000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_0_Q3_USD":19900000.0,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-2.68,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-0.97,"ProfitLoss_3_Q3_USD":-186655000.0,"StockholdersEquity_0_Q3_USD":1107098000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q3_USD":63023000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":9888000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q3_USD":814155000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_3_Q3_USD":-4970000.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":32448000.0,"AccruedProfessionalFeesCurrent_0_Q3_USD":2561000.0,"Ticker":"NTLA","CIK":"1652130","name":"INTELLIA THERAPEUTICS, INC.","OfficialName":"Intellia Therapeutics Inc. Common Stock","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"3","uom":"USD","footnote":"nan","Market Cap":"4259315236.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: In Vitro & In Vivo Diagnostic Substances","Market":"NASDAQ","SP500":"nan","filed":"20211104"}]